Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease

ConferenceAlloNK®Positive

AI Analysis

Artiva Biotherapeutics announced an oral presentation of AlloNK® clinical data at the 17th International Symposium on Sjögren's Disease.

Importance:4/10

Sentiment:

0.30

clinical_dataoral_presentationconferenceAlloNKSjögren's_Disease

Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 23, 2026 11:30 AM